RxDoctor Payments Data

Peter Naylor, MD

Psychiatry · North Charleston, SCNPI 1730133091

Payments from drug & device makers

$2,778in general payments, 2019–2025

Across 179 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$525
  • AbbVie$515
  • Takeda Pharmaceuticals U.S.A., Inc.$328
  • Otsuka America Pharmaceutical, Inc.$232
  • Johnson & Johnson$221
  • Supernus Pharmaceuticals, Inc.$170
  • plus $786 from 14 others

What the payments were for

  • Food & beverage$2,778100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,778 in reported general payments places this provider in the 80th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Medicare billing

Part B allowed, 2024
$90,644
Medicare patients
143
Services billed
977

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl17$26,348
Quetiapine Fumarate187$4,512
Bupropion XlBupropion Hcl194$4,189
Buspirone Hcl248$3,770
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine88$2,747
Ziprasidone Hcl44$2,317
Hydroxyzine Hcl107$2,117
Duloxetine Hcl115$1,992
Vilazodone Hcl22$1,973
Venlafaxine Hcl ErVenlafaxine Hcl126$1,793
Lamotrigine194$1,719
Trazodone Hcl207$1,533
Oxcarbazepine68$1,314
Alprazolam179$1,285
Clonazepam142$1,020

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$515$26,34817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in North Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →